Neurofibromatosis type 2 (NF2) is an autosomal dominant disease that is characterized mainly by schwannomas, as well as menigiomas and gliomas. The NF2 gene product merlin/schwannomin acts as a tumor suppressor. Schwann cells derived from NF2 schwannomas showed an enhanced proliferation rate, and electrophysological studies revealed larger K ؉ outward currents as compared with controls. Schwann cells isolated from schwannomas of NF2 patients or multiorgan donors were treated with different concentrations of the K ؉ current blockers quinidine, tetraethylammonium chloride, and 4-aminopyridine and K ؉ outward currents and proliferation rates of these cells were compared. K ؉ outward currents of both cell types can be blocked by quinidine. Importantly, treatment with quinidine reduces proliferation of NF2 Schwann cells in a concentration dependent manner but did not reduce proliferation of normal Schwann cells. Therefore, the use of quinidine or quinidine-like components would possibly provide a novel adjuvant therapeutic option for NF2 patients to slow down or freeze growth of schwannomas.
INTRODUCTION
Neurofibromatosis type 2 (NF2) is an autosomal dominant disease with an incidence of 1:37,000. This disorder is caused by alterations in the NF2 gene (Trofatter et al., 1993; Rouleau et al., 1993) and is characterized by bilateral vestibular schwannomas, cerebral meningiomas, and gliomas. In NF2 schwannomas, loss of heterozygosity (LOH) for polymorphic markers flanking or located within the NF2 locus on chromosome 22 and a high frequency of inactivating mutations of the NF2 gene support the hypothesis that the NF2 gene product merlin also acts as a tumor suppressor (Rouleau et al., 1987; Seizinger et al., 1987a, b; Twist et al., 1994; Sainz et al., 1994) . Patients with a defined germline mutation can acquire a second hit in the other allele which then leads to tumor formation according to the Knudson hypothesis (Knudson, 1971) . Perturbation of merlin synthesis by NF2 antisense oligodeoxynucleotides in Schwann-like cells leads to morphological changes and increased cell proliferation, indicating merlin's role as a tumor suppressor (Huynh and Pulst, 1996) . Overexpression of full-length wild-type merlin but not mutant merlin proteins in rat schwannoma cell lines results in growth inhibition (Sherman et al., 1997; Gutmann et al., 1999) . Furthermore, merlin was found to reverse the Rasinduced malignant phenotype in Ras-transformed fibroblasts (Tikoo et al., 1994) . The vestibular schwan-
